AMY WOODS: Open Payments
NPI 1013306067 · RUSSELLVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 14 payments from 4 companies in 2025. Trend: 2023 $165 · 2024 $132 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $179 |
| ABBVIE INC. | 5 | $105 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, GVOKE HYPOPEN.
Industry payments across AL — which companies pay providers there.
